» Authors » Samir Kumar-Singh

Samir Kumar-Singh

Explore the profile of Samir Kumar-Singh including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 99
Citations 4426
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Van Dingenen L, Segers C, Wouters S, Mysara M, Leys N, Kumar-Singh S, et al.
Front Cell Infect Microbiol . 2023 Nov; 13:1298264. PMID: 38035338
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers and poses a major burden on the human health worldwide. At the moment, treatment of CRC consists of surgery...
12.
Chenane H, Lingas G, Menidjel R, Laouenan C, Tubiana S, Descamps D, et al.
J Med Virol . 2023 Nov; 95(11):e29247. PMID: 38009713
The presence of free severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid-antigen in sera (N-antigenemia) has been shown in COVID-19 patients. However, the link between the quantitative levels of N-antigenemia...
13.
Neuhann J, Stemler J, Carcas A, Frias-Iniesta J, Akova M, Bethe U, et al.
Vaccine . 2023 Nov; 41(48):7166-7175. PMID: 37919141
Background: Vaccination remains crucial for protection against severe SARS-CoV-2 infection, especially for people of advanced age, however, optimal dosing regimens are as yet lacking. Methods: EU-COVAT-1-AGED Part A is a...
14.
Gentilotti E, Gorska A, Tami A, Gusinow R, Mirandola M, Rodriguez Bano J, et al.
EClinicalMedicine . 2023 Sep; 62:102107. PMID: 37654668
Background: Lack of specific definitions of clinical characteristics, disease severity, and risk and preventive factors of post-COVID-19 syndrome (PCS) severely impacts research and discovery of new preventive and therapeutics drugs....
15.
Giannella M, Huth M, Righi E, Hasenauer J, Marconi L, Konnova A, et al.
Clin Microbiol Infect . 2023 May; 29(8):1084.e1-1084.e7. PMID: 37150358
Objectives: The study aim was to assess predictors of negative antibody response (AbR) in solid organ transplant (SOT) recipients after the first booster of SARS-CoV-2 vaccination. Methods: Solid organ transplant...
16.
Gupta A, Konnova A, Smet M, Berkell M, Savoldi A, Morra M, et al.
J Clin Invest . 2023 Feb; 133(6). PMID: 36727404
BackgroundThe role of host immunity in emergence of evasive SARS-CoV-2 Spike mutations under therapeutic monoclonal antibody (mAb) pressure remains to be explored.MethodsIn a prospective, observational, monocentric ORCHESTRA cohort study, conducted...
17.
Konnova A, De Winter F, Gupta A, Verbruggen L, Hotterbeekx A, Berkell M, et al.
Front Immunol . 2023 Jan; 13:1062136. PMID: 36618384
Background: Patients with cancer, especially hematological cancer, are at increased risk for breakthrough COVID-19 infection. So far, a predictive biomarker that can assess compromised vaccine-induced anti-SARS-CoV-2 immunity in cancer patients...
18.
Wheatley R, Diaz Caballero J, van der Schalk T, De Winter F, Shaw L, Kapel N, et al.
Nat Commun . 2022 Nov; 13(1):6523. PMID: 36414617
Bacteria have the potential to translocate between sites in the human body, but the dynamics and consequences of within-host bacterial migration remain poorly understood. Here we investigate the link between...
19.
Savoldi A, Morra M, Castelli A, Mirandola M, Berkell M, Smet M, et al.
Biomedicines . 2022 Sep; 10(9). PMID: 36140162
The clinical impact of anti-spike monoclonal antibodies (mAb) in Coronavirus Disease 2019 (COVID-19) breakthrough infections is unclear. We present the results of an observational prospective cohort study assessing and comparing...
20.
Rosu G, Mateescu V, Simionescu A, Istrate-Ofiteru A, Curca G, Pirici I, et al.
Eur J Neurol . 2022 Sep; 29(12):3676-3692. PMID: 36056566
Background And Purpose: In the central nervous system, a multitude of changes have been described associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, such as microglial activation, perivascular...